This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Japanese operators of contact-tracing app cautioned by privacy commission

( May 1, 2020, 09:00 GMT | Official Statement) -- MLex Summary: Japanese operators of smartphone applications to track Covid-19 patients were cautioned by the privacy commission to protect the app users’ privacy rights to win their trust. The Personal Information Protection Commission said the contact-tracing app under development could be a very useful tool to prevent the spread of novel coronavirus, but that the mishandling of tests and their contact histories could violate users’ rights. Thus, downloading the app should be voluntary, and the app operators should aim to win users’ trust through transparent management, appropriate security measures, and adherence to the Japanese privacy law, the commission said in a statement.  For further details on how to track all MLex coverage on Covid-19’s impact, click here. For an overview case file bringing together all fields of Covid-19 coverage, see here....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections